Inovio Pharmaceuticals, Inc. (INO) Posts Q1 Loss of 6c/Share
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $10.02 --0%
Revenue Growth %: +490.9%
Financial Fact:
Total operating expenses: 32.74M
Today's EPS Names:
SFST, VLTO, CLIR, More
Revenue Growth %: +490.9%
Financial Fact:
Total operating expenses: 32.74M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Inovio Pharmaceuticals, Inc. (AMEX: INO) reported Q1 EPS of ($0.06), $0.02 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $1.7 million versus the consensus estimate of $2.1 million.
For earnings history and earnings-related data on Inovio Pharmaceuticals, Inc. (INO) click here.
For earnings history and earnings-related data on Inovio Pharmaceuticals, Inc. (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
- Northwest Bancshares, Inc. (NWBI) PT Lowered to $10 at Piper Sandler
- JetBlue Airways (JBLU) stock dips as revenue declines
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
